AVROBIO Inc. (AVRO) Reports New Interim Safety Data Across Investigational Gene Therapies for Fabry and Gaucher Disease Type 1 Oct 19, 2021 07:11AM
AVROBIO Reports New Interim Safety Data Across Investigational Gene Therapies for Fabry and Gaucher Disease Type 1 Oct 19, 2021 07:00AM
AVROBIO Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Update Mar 18, 2021 07:00AM
AVROBIO Inc. (AVRO) Reports New Positive Clinical Data and Preclinical Data for Lysosomal Disorder Gene Therapy Pipeline Nov 17, 2020 07:03AM
AVROBIO Announces New Positive Clinical Data and Preclinical Data, as Well as Expanded Leading Lysosomal Disorder Gene Therapy Pipeline Nov 17, 2020 07:00AM